Articles for GlaxoSmithKline (LSE: GSK)

GlaxoSmithKline plc is one of 10 top stocks for a Footsie starter portfolio

G A Chester's quarterly review of 10 FTSE 100 (INDEXFTSE:UKX) industry giants, including GlaxoSmithKline plc (LON:GSK). More »

Why I’d buy GlaxoSmithKline plc for its 5%+ dividend yield today

Edward Sheldon explains why he sees appeal in GlaxoSmithKline plc's (LON:GSK) 5.4% dividend yield. More »

Why I’d buy this biotechnology star alongside GlaxoSmithKline plc

This great growth prospect should nicely complement solid dividends from GlaxoSmithKline plc (LON: GSK). More »

One long-term growth stock I’d buy alongside GlaxoSmithKline plc

Royston Wild explains why GlaxoSmithKline plc (LON: GSK) isn’t the only great growth stock out there. More »

This four-bagger should continue to thrash GlaxoSmithKline plc

Harvey Jones says that ailing pharmaceuticals giant GlaxoSmithKline plc (LON: GSK) looks even more sluggish when set against this healthcare multi-bagger. More »

Why GlaxoSmithKline plc is the only pharma stock I’d ever own

In a volatile industry, GlaxoSmithKline plc (LON: GSK) stands out for its reliable growth, high dividend and bargain valuation. More »

An exciting pharma stock to consider alongside GlaxoSmithKline plc

GlaxoSmithKline plc (LON: GSK) would make a great pairing with this potential blockbuster growth firm. More »

Why I’ve sold this turnaround stock to buy GlaxoSmithKline plc

GlaxoSmithKline plc (LON: GSK) seems to have a better risk/reward ratio than this struggling business. More »

Is Neil Woodford wrong about British American Tobacco plc and GlaxoSmithKline plc?

Should you follow Neil Woodford and sell GlaxoSmithKline plc (LON: GSK) and British American Tobacco plc (LON: BATS)? More »

GlaxoSmithKline plc or Imperial Brands plc: which FTSE 100 favourite will be first to slash its dividend?

Reliant on GlaxoSmithKline plc (LON:GSK) or Imperial Brands plc (LON:IMB) for income? You need to read this. More »

Hikma Pharmaceuticals plc’s pain could be GlaxoSmithKline plc’s gain

Could ongoing approval issues at Hikma Pharmaceuticals plc (LON: HIK) and rivals help GlaxoSmithKline plc (LON:GSK) preserve its dividend? More »

Why I think Woodford was right to dump GlaxoSmithKline plc

Roland Head gives his verdict on the latest figures from GlaxoSmithKline plc (LON:GSK). More »

Should you follow Neil Woodford and dump GlaxoSmithKline plc?

Is it time to sell GlaxoSmithKline plc (LON: GSK)? More »

Neil Woodford has just bought Lloyds Banking Group plc and sold GlaxoSmithKline plc

Here's why Neil Woodford has backed Lloyds Banking Group plc (LON:LLOY) and dumped GlaxoSmithKline plc (LON:GSK). More »

3 powerful reasons to desire GlaxoSmithKline plc right now

Bilaal Mohamed gives investors three good reasons to consider high-yielding pharmaceuticals giant GlaxoSmithKline plc (LON:GSK). More »

2 FTSE 100 giants primed to outperform the index in the long term

These two high quality stocks can continue to trounce the cyclical FTSE 100 (INDEXFTSE: UKX). More »

Last chance to buy GlaxoSmithKline plc for under £16?

Is now the perfect time to buy a stake in GlaxoSmithKline plc (LON:GSK)? More »

2 FTSE 100 dividend stocks for beginners

If you don't know where to start, these dividend stocks can help you build your portfolio from scratch. More »

This fast-growing pharmaceutical stock blows GlaxoSmithKline plc out of the water

These two different stocks in the same sector strike a happy balance, says Harvey Jones. More »

2 top Neil Woodford stocks for your ISA

Should you follow Neil Woodford for your 2017 ISA picks? More »